Search results
Results From The WOW.Com Content Network
DEA lawsuit NO. 20-71433, the Ninth Circuit dismissed a petition that asked the court to review the DEA's denial of a letter that requested the agency reschedule marijuana. Under the CSA, the DEA must begin investigating the rescheduling of a drug after receiving a petition by from any interested party, including the manufacturer of a drug, a ...
After the DEA reviews and considers the public comments, and at the conclusion of any requested hearing, the DEA will issue a final order to reschedule marijuana. (The DEA could decline to ...
The Drug Enforcement Administration is expected to approve an opinion by the Department of Health and Human Services that marijuana should be reclassified from the most strict Schedule I to the ...
In a move that could significantly impact the cannabis reform landscape, the Drug Enforcement Administration (DEA) announced a delay on Monday in the rescheduling of marijuana, noting it would ...
Rescheduling marijuana will not resolve the conflict between the CSA and the laws of the 38 states that recognize cannabis as a medicine, 24 of which also allow recreational use. State-licensed ...
But the decision to reschedule marijuana is due in large part to its lower public health risk, federal scientists have said. In a leaked HHS document , officials wrote to the DEA to support ...
George Mason University. Known for. Marijuana reform activism. Jon B. Gettman (born August 20, 1957) is a marijuana rights activist, a leader of the Coalition for Rescheduling Cannabis, and a former head of the National Organization for the Reform of Marijuana Laws. He has a PhD in public policy and regional economic development from George ...
The Federal administrative process that began with President Biden's directive in 2022, and in 2023 with a recommendation by the Department of Health and Human Services to reschedule cannabis to Schedule III of the Controlled Substances Act was incomplete at the beginning of 2024. [1]